Grand Pharmaceutical Group Limited (0512.HK) HKSE

8.27

+0.1(+1.22%)

Updated at October 20 11:58AM

Currency In HKD

Grand Pharmaceutical Group Limited

Address

The Center

Central,

Hong Kong

Phone

N/A

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

11987

First IPO Date

December 19, 1995

Key Executives

NameTitlePayYear Born
Mr. Chao ZhouChief Executive Officer & Executive Director2.48M1990
Ms. Chit Yee LamExecutive Director17,0001966
Mr. Guang YangExecutive Director50,0001977
Dr. Weikun TangExecutive Chairman3.01M1986
Mr. Xiaofeng ShiChairman of Grand Pharm (China)01967
Xiaojie ChenVice President0N/A
Mr. Tin Chang Foo CPA (Aust.), HKICPACompany Secretary01969
Liu HuInvestor Relations Director0N/A

Description

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers pharmaceutical preparations, including cerebro-cardiovascular emergency medicines; respiratory, ophthalmic, anti-infection, and ENT medicines; oncology medicines; and rare disease medicines. It also provides medical devices, such as vascular interventional medical devices comprising paclitaxel releasing coronary balloon dilatation catheters and paclitaxel releasing hemodialysis shunt balloon dilatation catheters; and ophthalmology related devices. In addition, the company offers biotechnology and health products, such as Taurine, amino acid products, steroid products, and bio-pesticides and agricultural antibiotics; and specialized pharmaceutical raw materials and other products, including metronidazole, chloramphenicol, epinephrine, dimethyl sulfate, nitromethane, etc. Further, the company offers agrochemicals, fine chemicals, and chemical medicines; ophthalmic gel and eye drops; steroid hormones active pharmaceutical ingredients and related intermediates; bio-pesticides and additives; disposal surgical products; and Chinese medicine and health food products, as well as engages in the treatment of sewage. Grand Pharmaceutical Group Limited has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited and changed its name to Grand Pharmaceutical Group Limited in November 2021. Grand Pharmaceutical Group Limited was incorporated in 1995 and is based in Central, Hong Kong.